Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Survival Statistics for Some Common Cancers

Survival Statistics for Some Common Cancers

This article summarizes, for different cancers, median 5-year survival times. The most commonly used survival statistic in cancer is the 5-year survival rate, which indicates the percentage of patients who live for at least 5 years after being diagnosed with cancer.

Factors affecting success and survival rates in oncology

Various factors can affect how successful cancer treatments are and a patient's survival rate.

Survival rates can also help people understand patients with a similar diagnosis, because they provide information about the likely outcomes of people with similar cancers.

It is important to remember that a number of factors affect survival rates and treatment success rates. Differences in survival rates from person to person mainly depend on the following 3 factors:

  1. Type of cancer
  2. Cancer grade: A measure of how abnormal cancer cells look under a microscope. Grade is the term used, and high-grade tumors have more abnormal cells, suggesting that the cells grow and spread more quickly. 
  3. Cancer stage: Cancer stage indicates how large a tumor is and how far its cells have spread (whether it has metastasized). To determine the stage of cancer, we use various imaging tests .

The 0-5 staging system is most commonly used to stage cancers:

  • Stage 0: Abnormal cells are present but have not spread to nearby cells.
  • Stages 1, 2 and 3: Cancer is present, but there is no spread to distant tissues and organs. As the stage increases from 1 to 3, this means the tumor has increased in size and spread more extensively in the region.
  • Stage 4: Cancer metastasis has occurred (spread to other parts of the body). Researchers collecting data to determine cancer statistics may use the following terms to describe the cancer stage:
  • In situ (in place): Abnormal cells are present but have not spread to nearby tissues. 
  • Localized: The cancer has not spread beyond the site where it first developed. It is an early stage (stage 1-2).
  • Regional: Also called "regional" or "locally advanced". Cancer has spread to nearby lymph nodes, tissues or organs (stage 3).
  • Distant: Cancer has spread to distant parts of the body (stage 4).

Other factors affecting treatment outcomes:

The statistics below are taken from the American Cancer Society's 2016-2017 report on cancer treatment and survival.

This report uses 5-year relative survival rates, which describe the percentage of people living at least 5 years after a cancer diagnosis.

Breast cancer

Most people with stage 1, 2 or 3 breast cancer undergo, as part of their treatment, breast cancer surgery .

Some patients undergo a mastectomy, in which a surgeon removes the entire breast. Others may have breast-conserving surgery (BCS), which involves removing the tumor and some of the surrounding healthy tissue (see Which surgical method should be used for which patients in breast cancer surgery?)

Some patients receive tumor-shrinking chemotherapy before surgery (neoadjuvant) or protective chemotherapy after surgery (adjuvant).

Breast cancer survival statistics

The table below shows survival rates among women with breast cancer according to the stage at diagnosis:

Colorectal cancers

This means colon or rectal cancer .

Surgical options for colorectal cancer:

  • Colectomy: Removal of part or all of the colon. 
  • Proctectomy: Removal of part or all of the rectum. 
  • Proctocolectomy: Removal of part or all of the rectum and colon.

Colorectal cancer survival statistics

The table below provides information on survival rates for people with colorectal cancer according to the stage at diagnosis.

Non-Hodgkin lymphoma

Non-Hodgkin lymphoma, is a type of cancer that begins in cells called lymphocytes. These are immune system cells that help the body fight infection.

Approximately % 69 of patients with non-Hodgkin lymphoma receive chemotherapy. Of these, % 58 receive chemotherapy alone, while % 11 receive chemotherapy and radiotherapyin combination.

Non-Hodgkin lymphoma survival statistics

The table below provides information on survival rates for patients with non-Hodgkin lymphoma according to the stage at diagnosis.

Lung cancer

There are two main types of lung cancer: small cell and non-small cell.

Approximately % 135 of lung cancers are small cell. Effective treatment options for patients with small cell lung cancer are chemotherapy, immunotherapy and radiotherapy.

Approximately % 80 of lung cancers are non-small cell. The remaining % 5 are those whose cellular subtype cannot be determined.

Lung cancer survival statistics

The table below shows survival rates for people with non-small cell lung cancer according to the stage at diagnosis.

- New targets, new hopes in lung cancer treatment – 2019

Testicular cancer

Testicular cancer, is cancer in one or both testicles. Approximately % 97 of testicular cancers begin in germ cells. These are cells that develop into sperm.

Tumors developing from germ cells are called testicular germ cell tumors. There are two types: seminoma tumors, which tend to grow slowly, and non-seminoma tumors, which generally grow more quickly.

Testicular cancer survival statistics

The table below provides information on survival rates for men with testicular cancer according to the stage at diagnosis. These figures combine data from both types of testicular tumors.

- 1 cycle of BEP found sufficient for postoperative adjuvant chemotherapy in testicular cancer

Bladder cancer

Early-stage bladder cancer is often treated with cystectomy surgery. Most patients with bladder cancer undergo one of the following operations:

  • Transurethral resection of a bladder tumor (TUR-M), a minimally invasive procedure involving removal of the bladder tumor through the urethra.
  • Cystectomy, removal of part or all of the bladder, along with the surrounding fatty tissue and lymph nodes.

Bladder cancer survival statistics

The 5-year relative survival rate for early-stage bladder cancer varies according to the cancer type. Approximately % 25 of bladder cancers invade the muscular wall of the bladder.

The 5-year relative survival rate is % 47 for locally advanced (muscle-invasive) bladder cancer and % 81 for non-muscle-invasive bladder cancer.

The table below shows further information on survival rates for people with bladder cancer according to the stage at diagnosis.

Uterine cancer

More than % 90 of uterine cancers occur in the endometrium, the inner part of the uterus, and are called endometrial cancer .

Endometrial cancer survival statistics

The table below shows information on survival rates for people with endometrial cancer according to the stage at diagnosis.

Summary

Many factors, including cancer type, stage, age, general health and access to treatments, affect treatment success.

Survival rates, based on outcomes in people diagnosed with similar cancers, provide only an estimate . In addition, newly approved treatments can show their contribution to survival rates only within 5-10 years.

Your doctor can take all relevant factors into account and provide a better understanding for individual circumstances.

Sources

NCI's Surveillance, Epidemiology, and End Results (SEER) program.
seer.cancer.gov - Erişim 23 Ağustos 2019.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Survival Statistics for Some Common Cancers

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy